is dsip fda approved Injectable DSIP Nasal Spray, 5mg (Delta

Complementary effects to more targeted peptides

OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship

Bone healing: Enhanced callus formation and mineralization measurable at 6 weeks in pseudoarthrosis models (Krivic et al., 2006)

8 How Are Chemyos Products Administered

Surprisingly this is where we stand on the IT Band after more than a decade of research

Hypoxia and Oxidative Measurements Rat studies examined mitochondrial respiration, antioxidant-gene expression and resistance to experimental hypoxia